Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in Mycobacterium abscessus

Authors:

Abstract
Mycobacterium abscessus is a rapidly growing non-tuberculous mycobacteria that is quickly emerging as a global health concern. M. abscessus pulmonary infections are frequently intractable due to the high intrinsic resistance to most antibiotics. Therefore, there is an urgent need to discover effective pharmacological options for M. abscessus infections. In this study, the potency of the anti-tuberculosis drug Telacebec (Q203) was evaluated against M. abscessus. Q203 is a clinical-stage drug candidate targeting the sub-unit QcrB of the cytochrome bc1:aa3 terminal oxidase. We demonstrated that the presence of four naturally-occurring polymorphisms in the M. abscessus QcrB are responsible for the high resistance of the bacterium to Q203. Genetics reversion of the four polymorphism sensitized M. abscessus to Q203. While this study highlights the limitation of a direct drug repurposing approach of Q203 and related drugs for M. abscessus infections, it reveals that the M. abscessus cytochrome bc1:aa3 respiratory branch is sensitive to chemical inhibition.
Funding Information
  • Nanyang Technological University
  • Institute for Health Technologies, Nanyang Technological University
  • Lee Kong Chian School of Medicine, Nanyang Technological University

This publication has 31 references indexed in Scilit: